# Paris:SAN news releases

Paris:SAN press releases distributed through Connectively Wire to the journalists who cover the beat.

- **Releases in the last 90 days:** 271
- **Web page:** https://www.connectively.us/news-releases/parissan
- **RSS:** https://www.connectively.us/news-releases/parissan/rss.xml

### [Press Release: Sanofi’s Infilbray approved in the US as the first medicine to treat neurological manifestations of Type 3 Gaucher disease](https://www.connectively.us/news-releases/press-release-sanofis-infilbray-approved-in-the-us-as-the-first-2)

November 18, 2026 · Sanofi · Paris:SAN

Sanofi’s Infilbray approved in the US as the first medicine to treat neurological manifestations of Type 3 Gaucher disease Infilbray is a once-daily oral medicine that acts across the blood-brain barrier, targeting devastating neurological manifestations associated with GD3 GD3…
